Workflow detail

Field brief

Prior authorization packet / response workflow

Start here because prior authorization is a payer-provider workflow with visible burden, document-heavy evidence, and clear regulatory momentum. AI can assemble clinical and administrative context, but medical necessity, approval, denial, and appeal decisions remain human-owned.

IndustryHealthcare
Decision ownerUtilization reviewer
AI boundaryAssist only
Governancehigh

Why this workflow is viable first

Prior authorization is a concrete payer-provider workflow, not a generic healthcare transformation theme.

The work depends on assembling clinical, coding, eligibility, payer policy, and status evidence from known sources.

AI can assist with packet assembly, missing-evidence detection, requirement comparison, and draft follow-up while humans own approval, denial, and appeal decisions.

Success can be measured through cycle time, first-pass approval, missing-evidence rate, touch count, denial overturn, and patient scheduling delay.

Value leakage to inspect

  • Incomplete authorization packets
  • Manual clinical document collection
  • Unclear payer-specific requirements
  • Repeated provider-payer follow-up
  • Delayed response and status visibility

Bounded AI role

  • Assemble authorization packet
  • Detect missing clinical evidence
  • Compare to payer requirements
  • Draft payer follow-up or appeal packet

Human-owned controls

  • AI does not decide medical necessity, approval, denial, appeal outcome, or clinical appropriateness.
  • Utilization reviewer, clinician, or authorization specialist verifies summaries, missing evidence, and payer requirement comparisons.
  • Payer policy and clinical review rules determine which human owns approval, denial, or escalation.
  • The workflow should retain source evidence, submissions, responses, communications, and rationale for appeal or audit review.

Do not automate

  • Recommend medical necessity decision
  • Approve, deny, or overturn authorization

Pilot KPIs — establish baselines before the pilot starts

Measure these before the first case runs. The pilot result is the delta, not the absolute value.

daysAuthorization cycle timeAverage days from request submission to payer decision, last 30 authorizations
%First-pass approval ratePercentage of requests approved without a payer request for additional information
%Missing evidence ratePercentage of requests generating a payer request for additional information
%Denial overturn ratePercentage of denied requests successfully overturned on appeal

Governance profile

Data sensitivityregulated

AI is permitted to

  • Assemble prior authorization packet from clinical and administrative sources
  • Detect missing clinical evidence against payer-specific requirements
  • Compare request details to payer medical necessity criteria and flag gaps
  • Draft status updates and follow-up messages for human review and approval
  • Prepare appeal evidence packet for human submission

Retain for audit

  • Clinical and coding source evidence referenced in each packet
  • Payer requirement comparison and gap notes
  • Communication drafts and human approval record
  • Authorization decisions, denials, and appeal outcomes with supporting rationale
  • Patient access delays linked to authorization status for compliance review

30/60/90 adoption path

Move from evidence inspection to one-team pilot before expanding the pattern.

30 daysSelect one authorization category + Inspect recent request and denial files
60 daysPilot with one provider or payer operations team + Add missing evidence detection
90 daysExpand to adjacent authorization categories + Connect to status and response workflow

After 90 days

After prior authorization is proven, the same evidence-assembly pattern applies to appeals and grievances, referral management, and care coordination documentation — all share the clinical-and-administrative context structure.

Human-owned decision. AI role bounded to preparation, comparison, drafting, and evidence assembly.
AI Adoption Pathfinder